Literature DB >> 17935720

Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B.

Chia-Ming Chu1, Yun-Fan Liaw.   

Abstract

BACKGROUND & AIMS: Predictors of reactivation of hepatitis B following hepatitis B e antigen (HBeAg) seroconversion in chronic hepatitis B have rarely been reported before and deserve further study.
METHODS: A total of 133 HBeAg-positive asymptomatic carriers who have undergone HBeAg seroconversion were studied. Reactivation of hepatitis B was defined as elevation of alanine aminotransferase >2 x upper normal limit accompanied by serum hepatitis B virus DNA detectable by hybridization assays.
RESULTS: The samples consisted of 75 men and 58 women, and the mean age at entry was 28.2 +/- 6.9 years. One hundred eight subjects had genotype B, and 25 had genotype C. The maximal alanine aminotransferase levels during the HBeAg-positive phase were <2, 2-5, and >5 x upper normal limit in 49, 40, and 44 subjects, respectively. HBeAg seroconversion occurred after a mean follow-up of 4.6 +/- 3.7 years. During a mean follow-up of 5.8 +/- 4.6 years following HBeAg seroconversion, reactivation of hepatitis B occurred in 26 patients at 3.3% per year. Multivariate analyses demonstrated that reactivation of hepatitis B correlated significantly with genotype C (P = .003), male sex (P = .03), alanine aminotransferase levels >5 x upper normal limit during the HBeAg-positive phase (P = .02), and age at HBeAg seroconversion >/=40 years (P = .002).
CONCLUSIONS: At baseline, genotype C and male sex are independent factors predictive of reactivation of hepatitis B. Additionally, the likelihood of reactivation of hepatitis B is increased if more rigorous immune-mediated hepatocytolysis or more prolonged immune clearance phase is necessary to eliminate the virus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17935720     DOI: 10.1053/j.gastro.2007.08.039

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  43 in total

1.  Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.

Authors:  Chia-Ming Chu; Chen-Chun Lin; Shi-Ming Lin; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2011-08-12       Impact factor: 3.199

2.  Rates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.

Authors:  Rania A Tohme; Lisa Bulkow; Chriss E Homan; Susan Negus; Brian J McMahon
Journal:  J Clin Virol       Date:  2013-08-16       Impact factor: 3.168

Review 3.  Approach to clinical syndrome of jaundice and encephalopathy in tropics.

Authors:  Anil C Anand; Hitendra K Garg
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

4.  High risk of hepatitis B virus reactivation in nucleos(t)ide analogue-induced hepatitis B e antigen seroconverters older than 40 years.

Authors:  Li-Fu Kuo; Chuan-Mo Lee; Chao-Hung Hung; Jing-Houng Wang; Tsung-Hui Hu; Sheng-Nan Lu; Chi-Sin Changchien; Chien-Hung Chen
Journal:  Dig Dis Sci       Date:  2014-05-21       Impact factor: 3.199

Review 5.  Management of HBV and HBV/HDV-Associated Liver Cirrhosis.

Authors:  Christoph Höner Zu Siederdissen; Markus Cornberg
Journal:  Visc Med       Date:  2016-04-12

Review 6.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

7.  Hepatobiliary Quiz Answers - 18 (2016).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2016-07-25

8.  Reactivation of hepatitis B: pathogenesis and clinical implications.

Authors:  Anthony Post; Shweta Nagendra
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

9.  HBV genotype C is independently associated with cirrhosis in community-based population.

Authors:  Jian-Hua Yin; Jun Zhao; Hong-Wei Zhang; Jia-Xin Xie; Wei-Ping Li; Guo-Zhang Xu; Jie Shen; Hong-Jun Dong; Jun Zhang; Lin Wang; Jian-Kang Han; Hong-Yang Wang; Guang-Wen Cao
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

10.  Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update.

Authors:  Yun-Fan Liaw; Nancy Leung; Jia-Horng Kao; Teerha Piratvisuth; Edward Gane; Kwang-Hyub Han; Richard Guan; George K K Lau; Stephen Locarnini
Journal:  Hepatol Int       Date:  2008-05-10       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.